Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06232 | 32961235 | Life Sci | Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice. | 2020 | Details |
| A06233 | 32960625 | Nutr Hosp | [Effectiveness of hydroxycinamates and beta-glucans as dietary tools against obesity and its associated dysfunctions, and their application as nutraceuticals]. | 2020 | Details |
| A06234 | 32960457 | J Ultrasound Med | Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis. | 2020 | Details |
| A06235 | 32959866 | Food Funct | Two polyphenol-rich Brazilian fruit extracts protect from diet-induced obesity and hepatic steatosis in mice. | 2020 | Details |
| A06236 | 32959331 | Obes Surg | Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study. | 2020 | Details |
| A06238 | 32958032 | Orphanet J Rare Dis | Consensus clinical management guidelines for Alström syndrome. | 2020 | Details |
| A06239 | 32957701 | Biomolecules | Rescue of Hepatic Phospholipid Remodeling Defectin iPLA2β-Null Mice Attenuates Obese but Not Non-Obese Fatty Liver. | 2020 | Details |
| A06240 | 32956824 | J Nutr Biochem | Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice. | 2020 | Details |
| A06241 | 32955731 | Int J Cancer | Associations of general obesity and central obesity with the risk of hepatocellular carcinoma in a Korean population: A national population-based cohort study. | 2020 | Details |
| A06242 | 32954243 | JHEP Rep | Stratification of patients in NASH clinical trials: A pitfall for trial success. | 2020 | Details |
| A06243 | 32953932 | Mol Ther Methods Clin Dev | Soluble Klotho Improves Hepatic Glucose and Lipid Homeostasis in Type 2 Diabetes. | 2020 | Details |
| A06244 | 32953808 | Ann Transl Med | Nonalcoholic fatty liver disease impacts the control of the international normalized ratio in patients with atrial fibrillation. | 2020 | Details |
| A06245 | 32952877 | World J Hepatol | Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis. | 2020 | Details |
| A06246 | 32952876 | World J Hepatol | Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update. | 2020 | Details |
| A06247 | 32952872 | World J Hepatol | Lipidomics in non-alcoholic fatty liver disease. | 2020 | Details |
| A06248 | 32952590 | Evid Based Complement Alternat Med | Schisandra Fruit Vinegar Lowers Lipid Profile in High-Fat Diet Rats. | 2020 | Details |
| A06249 | 32952552 | J Toxicol | Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro. | 2020 | Details |
| A06250 | 32952345 | World J Gastroenterol | Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis. | 2020 | Details |
| A06251 | 32952340 | World J Gastroenterol | Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice. | 2020 | Details |
| A06254 | 32951749 | Complement Ther Med | Effects of green coffee bean extract on C-reactive protein levels: A systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
| A06255 | 32951743 | Complement Ther Med | Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. | 2020 | Details |
| A06256 | 32951715 | Complement Ther Med | The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial. | 2020 | Details |
| A06257 | 32951697 | Complement Ther Med | The effect of melatonin supplementation on liver indices in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials. | 2020 | Details |
| A06258 | 32951410 | Clin Mol Hepatol | Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases. | 2020 | Details |
| A06259 | 32951289 | Physiol Rep | Targeted and untargeted metabolomics provide insight into the consequences of glycine-N-methyltransferase deficiency including the novel finding of defective immune function. | 2020 | Details |
| A06260 | 32949785 | Ann Hepatol | Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A06261 | 32948162 | BMC Complement Med Ther | Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway. | 2020 | Details |
| A06262 | 32947972 | Int J Mol Sci | NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling. | 2020 | Details |
| A06263 | 32947952 | Nutrients | Anti-Diabetic Obesity Effects of Wasabia Japonica Matsum Leaf Extract on 45% Kcal High-Fat Diet-Fed Mice. | 2020 | Details |
| A06264 | 32947869 | Biomolecules | Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent. | 2020 | Details |
| A06265 | 32947757 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease in males with low testosterone concentrations. | 2020 | Details |
| A06266 | 32947564 | J Pediatr Gastroenterol Nutr | Lipidomics in Nonalcoholic Fatty Liver Disease: Exploring Serum Lipids as Biomarkers for Pediatric Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06267 | 32946642 | Liver Int | Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review. | 2021 | Details |
| A06268 | 32946623 | Hepatol Res | Non-invasive fibrosis markers are associated with mortality risk in both general populations and non-alcoholic fatty liver disease patients. | 2020 | Details |
| A06269 | 32946502 | PLoS One | Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019. | 2020 | Details |
| A06270 | 32945983 | Dig Dis Sci | FAM172A Deletion May Enhance Hepatic Steatosis by Promoting ER Stress. | 2020 | Details |
| A06271 | 32945412 | Mol Med Rep | Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats. | 2020 | Details |
| A06272 | 32945408 | Mol Med Rep | Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats. | 2020 | Details |
| A06273 | 32945305 | Food Funct | Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice. | 2020 | Details |
| A06274 | 32945071 | Diabetes Obes Metab | A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer? | 2020 | Details |
| A06275 | 32945042 | Cancer Sci | System biology analysis reveals the role of voltage-dependent anion channel in mitochondrial dysfunction during non-alcoholic fatty liver disease progression into hepatocellular carcinoma. | 2020 | Details |
| A06277 | 32944984 | J Food Biochem | trans-Chalcone inhibits high-fat diet-induced disturbances in FXR/SREBP-1c/FAS and FXR/Smad-3 pathways in the kidney of rats. | 2020 | Details |
| A06278 | 32943763 | Int J Obes (Lond) | Modifications of IGF2 and EGFR plasma protein concentrations in NAFLD patients after bariatric surgery. | 2020 | Details |
| A06279 | 32943747 | Sci Rep | Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects. | 2020 | Details |
| A06280 | 32943694 | Sci Rep | A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis. | 2020 | Details |
| A06281 | 32943651 | Sci Rep | Punica granatum L.-derived omega-5 nanoemulsion improves hepatic steatosis in mice fed a high fat diet by increasing fatty acid utilization in hepatocytes. | 2020 | Details |
| A06282 | 32942921 | Scand J Rheumatol | Lupus hepatitis, more than just elevated liver enzymes. | 2020 | Details |
| A06283 | 32942773 | Molecules | New Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells. | 2020 | Details |
| A06284 | 32942044 | Cell Mol Gastroenterol Hepatol | Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner. | 2020 | Details |
| A06285 | 32941865 | Biochem Pharmacol | Aryl hydrocarbon receptor (AHR)-mediated inflammation and resolution: Non-genomic and genomic signaling. | 2020 | Details |
| A06286 | 32941676 | J Clin Hypertens (Greenwich) | Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease. | 2020 | Details |
| A06288 | 32940183 | Curr HIV Res | Association between Nonalcoholic Fatty Liver Disease and Bone Mineral Density in HIV-Infected Patients Receiving Long-term TDF-Based Antiretroviral Therapy. | 2021 | Details |
| A06289 | 32940033 | J Agric Food Chem | (-)-Hydroxycitric Acid Alleviates Oleic Acid-Induced Steatosis, Oxidative Stress, and Inflammation in Primary Chicken Hepatocytes by Regulating AMP-Activated Protein Kinase-Mediated Reactive Oxygen Species Levels. | 2020 | Details |
| A06290 | 32939922 | Hepatol Res | Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease. | 2020 | Details |
| A06291 | 32939691 | Adv Ther | A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06292 | 32939643 | Biol Trace Elem Res | Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver. | 2020 | Details |
| A06293 | 32938692 | Gut | Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. | 2020 | Details |
| A06294 | 32938556 | Obes Res Clin Pract | Effects of obesity reduction on transient elastography-based parameters in pediatric non-alcoholic fatty liver disease. | 2020 | Details |
| A06295 | 32937687 | Clin Mol Hepatol | Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake. | 2020 | Details |
| A06296 | 32937242 | Atherosclerosis | Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses. | 2020 | Details |
| A06297 | 32937194 | Mol Metab | Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis. | 2020 | Details |
| A06298 | 32937148 | Immunity | Two Roads Diverge in the Sick Liver, Monocytes Travel Both. | 2020 | Details |
| A06299 | 32936538 | Aging Cell | Aging-induced aberrant RAGE/PPARα axis promotes hepatic steatosis via dysfunctional mitochondrial β oxidation. | 2020 | Details |
| A06300 | 32936098 | J R Coll Physicians Edinb | Diagnosis and management of fatty liver. | 2020 | Details |
| A06301 | 32936063 | J Am Coll Nutr | Correlating Circulating Vitamin D3 with Aspects of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Healthy Female Volunteers. | 2020 | Details |
| A06302 | 32936018 | AJR Am J Roentgenol | Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1204 Healthy Adults Using Unenhanced CT as a Reference Standard. | 2020 | Details |
| A06303 | 32935743 | Arq Gastroenterol | DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH LOW LEVELS OF FREE COPPER AND OF CERULOPLASMIN. | 2021 | Details |
| A06304 | 32934967 | J Biol Methods | An in vitro model of hepatic steatosis using lipid loaded induced pluripotent stem cell derived hepatocyte like cells. | 2020 | Details |
| A06305 | 32934691 | Exp Ther Med | Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review). | 2020 | Details |
| A06306 | 32934047 | Clin Med (Lond) | Non-alcoholic fatty liver disease. | 2020 | Details |
| A06309 | 32933722 | Tissue Cell | Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats. | 2020 | Details |
| A06310 | 32933184 | Life (Basel) | Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome. | 2020 | Details |
| A06311 | 32933141 | Int J Mol Sci | Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population. | 2020 | Details |
| A06312 | 32932796 | Nutrients | Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A06313 | 32932674 | Molecules | Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases. | 2020 | Details |
| A06314 | 32932529 | Exp Clin Endocrinol Diabetes | Liver Expressed Antimicrobial Peptide 2 is Associated with Steatosis in Mice and Humans. | 2020 | Details |
| A06316 | 32932174 | J Trace Elem Med Biol | The effects of zinc supplementation on metabolic profile and oxidative stress in overweight/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. | 2020 | Details |
| A06317 | 32931760 | Am J Med | The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective. | 2020 | Details |
| A06318 | 32931733 | Cell | Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output. | 2020 | Details |
| A06319 | 32930860 | Wien Klin Wochenschr | Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease. | 2020 | Details |
| A06320 | 32930541 | Eur J Histochem | β-catenin mediates the effect of GLP-1 receptor agonist on ameliorating hepatic steatosis induced by high fructose diet. | 2020 | Details |
| A06322 | 32929325 | Theranostics | Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling. | 2020 | Details |
| A06323 | 32929103 | Sci Rep | Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study. | 2020 | Details |
| A06324 | 32928662 | Curr Probl Pediatr Adolesc Health Care | Updates in non-alcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A06325 | 32928581 | Clin Nutr | Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study. | 2020 | Details |
| A06326 | 32928450 | J Sport Health Sci | Regular moderate aerobic exercise improves high-fat diet-induced nonalcoholic fatty liver disease via monoacylglycerol O-acyltransferase 1 pathway suppression. | 2018 | Details |
| A06327 | 32927776 | Nutrients | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress. | 2020 | Details |
| A06328 | 32927075 | J Am Coll Surg | Preventive Effect of High-Dose Digestive Enzyme Management on Development of Nonalcoholic Fatty Liver Disease after Pancreaticoduodenectomy: A Randomized Controlled Clinical Trial. | 2020 | Details |
| A06329 | 32926803 | Am J Respir Crit Care Med | Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial. | 2021 | Details |
| A06330 | 32926754 | Hepatol Res | Effect of pemafibrate on fatty acid levels and liver enzymes in non-alcoholic fatty liver disease patients with dyslipidemia: A single-arm, pilot study. | 2020 | Details |
| A06331 | 32925501 | Eur J Gastroenterol Hepatol | Obstructive sleep apnea and severity of nonalcoholic fatty liver disease. | 2021 | Details |
| A06333 | 32925160 | J Xray Sci Technol | Diagnostic performance on multiple parameters of real-time ultrasound shear wave elastography for evaluating nonalcoholic fatty liver disease: A rabbit model. | 2020 | Details |
| A06334 | 32925017 | Clin Hemorheol Microcirc | The diagnostic performance of contrast-enhanced ultrasound (CEUS) for evaluating hepatocellular carcinoma (HCC) juxtaposed to MRI findings; a retrospective single-center analysis of 292 patients. | 2020 | Details |
| A06335 | 32924526 | Am J Physiol Endocrinol Metab | Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease. | 2020 | Details |
| A06336 | 32924000 | Metabol Open | The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study. | 2020 | Details |
| A06337 | 32923833 | Hepatol Commun | Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression. | 2020 | Details |
| A06338 | 32923831 | Hepatol Commun | Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH. | 2020 | Details |
| A06339 | 32923658 | Cannabis Cannabinoid Res | Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet. | 2020 | Details |
| A06340 | 32923108 | Am J Cardiovasc Dis | Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis. | 2020 | Details |
| A06342 | 32922442 | Front Genet | Does Cannabis Intake Protect Against Non-alcoholic Fatty Liver Disease? A Two-Sample Mendelian Randomization Study. | 2020 | Details |